JPRN-UMIN000014173招募中未知
18F-FMISO PET imaging and efficacy of eribulin in metastatic breast cancer - 18F-FMISO PET imaging in metastatic breast cancer
breast surgery Hokkaido University Hospital0 个研究点目标入组 20 人开始时间: 2014年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
18F-FES PET/MRI for tailoring treatment of luminal A and lobular breast cancer: a phase II trial evaluating the performance of FES PET/MRI in axillary stagingCTIS2024-512465-14-00niversita' Vita-salute S. Raffaele221
进行中（未招募）
不适用
To test the effectiveness of florbetapir (18F) as a diagnostic tool in subjects particpiating in the IRCCS-FBF protocolEUCTR2012-003079-20-ITAVID RADIOPHARMACEUTICALS, INC.
已完成
不适用
18F-FLT and 18F-FDG PET imaging for patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000010636Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui80
已完成
2 期
Florbetapir F18 (18F-AV-45) amyloid positron emission tomography (PET) imaging in focal dementia syndromesFocal dementia syndromes - primary aphasiaMental and Behavioural DisordersMulti-infarct dementiaISRCTN57388990Avid Radiopharmaceuticals Inc. (USA)25
进行中（未招募）
1 期
18F-fluoride PET for Early Non-invasive Assessment of Cortical Bone Formation - Non-invasive Assessment of Cortical Bone Formation - Version 1EUCTR2009-016523-61-GBKing’s College London30